Get started
Author

Ilana Struys

Association of Chemotherapy Timing in Pregnancy With Congenital Malformation
2021 · Mathilde van Gerwen, Charlotte Maggen, et al. · JAMA Network Open · 77
PDF
Development and validation of an UPLC-ESI–MS/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure
2024 · Eline Verscheure, Ilana Struys, et al. · Archives of Toxicology · 7
Association of Chemotherapy Timing in Pregnancy With Congenital Malformation
2021 · Mathilde van Gerwen, Charlotte Maggen, et al. · Obstetrical & Gynecological Survey · 5
PDF
Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2025 · Ilana Struys, Carolina Velázquez, et al. · Cancer Discovery · 4
PDF
Characterization of the genotoxic profile of antineoplastic drugs using the cytokinesis-block micronucleus cytome assay
2022 · Ilana Struys, Eline Verscheure, et al. · Environmental Toxicology and Pharmacology · 4
Novel next-generation sequencing-based methodologies to characterize the mutational consequences of (prenatal) chemotherapy exposure in noncancerous tissue
2021 · Ilana Struys, Liesbeth Lenaerts, et al. · Current Opinion in Oncology · 4
PDF
#506 Chemotherapy during pregnancy is associated with increased genotoxicity and mutational load in the fetal hematopoietic compartment
2023 · Ilana Struys, Carolina Velázquez, et al. · International Journal of Gynecological Cancer · 2
PDF
Additive genotoxic effects in cord blood cells upon indirect exposure to chemotherapeutic compounds crossing an in vitro placental barrier
2024 · Carolina Velazquez, Lien Loier, et al. · Scientific Reports · 1
PDF
Figure S3 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2026 · Ilana Struys, Carolina Velázquez, et al.
Figure S4 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2026 · Ilana Struys, Carolina Velázquez, et al.
Figure S5 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2026 · Ilana Struys, Carolina Velázquez, et al.
Figure S1 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2026 · Ilana Struys, Carolina Velázquez, et al.
Figure S2 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2026 · Ilana Struys, Carolina Velázquez, et al.
Data from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2025 · Ilana Struys, Carolina Velázquez, et al.
Figure S3 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2025 · Ilana Struys, Carolina Velázquez, et al.
Figure S5 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2025 · Ilana Struys, Carolina Velázquez, et al.
PDF
Tables S1-3 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2025 · Ilana Struys, Carolina Velázquez, et al.
Figure S4 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2025 · Ilana Struys, Carolina Velázquez, et al.
PDF
Figure S1 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2025 · Ilana Struys, Carolina Velázquez, et al.
PDF
Figure S2 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells
2025 · Ilana Struys, Carolina Velázquez, et al.
PDF
Abstract 7488: Prenatal exposure to chemotherapy increases the mutation burden in human neonatal hematopoietic stem cells
2025 · Ilana Struys, Carolina Velázquez, et al. · Cancer Research
Compound-dependent fetal toxicity after in utero exposure to chemotherapy in a pregnant mouse model
2024 · Ilana Struys, Ji-Ying Song, et al. · Environmental Toxicology and Pharmacology
P-364 Method Developement for Quantificiation of Cyclophosphamide, Doxorubicin, Daunorubicin, Epirubicin, Paclitaxel and Their Metabolites in Human Plasma
2024 · Eline Verscheure, Matteo Creta, et al. · Occupational Medicine
PDF
Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study
2024 · Ilana Struys, Carolina Velázquez, et al. · BMJ Open
PDF
Works count: 26
Citation count: 104
H-index: 4
I10-index: 1
Year
Topic
Type